Braveheart Bio Inc

NEW
NAS:BRVE (USA)  
$ 31.93 -0.84 (-2.72%) 10:08 PM EST
N/A
Volume:
565.61K
Avg Vol (2M):
3.29M
Trade In:
Volume:
565.61K
Avg Vol (2M):
3.29M

Business Description

Compare
Compare
Traded in other countries / regions
BRVE.USA
IPO Date
2026-08-06
Description
Braveheart Bio Inc is a clinical-stage biotechnology company focused on developing therapeutics to treat hypertrophic cardiomyopathy (HCM) and other cardiovascular diseases. Its flagship product candidate, BHB-1893, is an oral small-molecule cardiac myosin inhibitor being developed for the treatment of obstructive HCM (oHCM) and non-obstructive HCM (nHCM).
Name Current Vs Industry Vs History

Growth Rank

Name Current Vs Industry Vs History

Momentum Rank

Name Current Vs Industry Vs History

Liquidity Ratio

Name Current Vs Industry Vs History

Dividend & Buy Back

Name Current Vs Industry Vs History
Name Current Vs Industry Vs History

GF Value Rank

Name Current Vs Industry Vs History
PE Ratio
N/A
N/A
N/A
PE Ratio without NRI
N/A
N/A
N/A
FCF Yield %
-16900

Financials

BRVE's 30-Y Financials
Income Statement Breakdown FY
Not Enough Data
Balance Sheet Breakdown
Not Enough Data
Cashflow Statement Breakdown
Not Enough Data

Operating Revenue by Business Segment

Operating Revenue by Geographic Region

Historical Operating Revenue by Business Segment

Historical Operating Revenue by Geographic Region

5-Step DuPont Analysis as of
Not Enough Data

Guru Trades

See Details
To

Insider Trades

See Details
To

Gurus Latest Trades with NAS:BRVE

No Available Data

Peter Lynch Chart

Y-axis scale:
Interactive Chart
To

Performance

Dividend
Log
Bar
To

Annualized Return %  

Symbol
1 Week
1 Month
3 Months
6 Months
YTD
1 Year
3 Years
5 Years
10 Years

Total Annual Return %  

Symbol
2026
2025
2024
2023
2022
2021
2020
2019
2018
2017

Braveheart Bio Inc Executives

Details

GF Valueâ„¢

Valuation Chart

Year:

Analyst Estimate

Key Statistics

Name Value
Revenue (TTM) (Mil $)
EPS (TTM) ($) -5.32
Beta -
3-Year Sharpe Ratio -
3-Year Sortino Ratio -
Volatility % -
14-Day RSI -
14-Day ATR ($) -
20-Day SMA ($) -
12-1 Month Momentum % -
52-Week Range ($) 28.465 - 31.93
Shares Outstanding (Mil)

Piotroski F-Score Details

Year:
Component Result
Piotroski F-Score 0
Positive ROA
Positive CFROA
Higher ROA yoy
CFROA > ROA
Lower Leverage yoy
Higher Current Ratio yoy
Less Shares Outstanding yoy
Higher Gross Margin yoy
Higher Asset Turnover yoy

Braveheart Bio Inc Filings

Filing Date Document Date Form
No Filing Data

Braveheart Bio Inc Stock Events

Financials Calendars
Event Date Price ($)
No Event Data

Braveheart Bio Inc Frequently Asked Questions

What is Braveheart Bio Inc(BRVE)'s stock price today?
The current price of BRVE is $31.93. The 52 week high of BRVE is $31.93 and 52 week low is $28.47.
When is next earnings date of Braveheart Bio Inc(BRVE)?
The next earnings date of Braveheart Bio Inc(BRVE) is .
Does Braveheart Bio Inc(BRVE) pay dividends? If so, how much?
Braveheart Bio Inc(BRVE) does not pay dividend.

Guru Commentaries on NAS:BRVE

No articles.

Press Release

Subject Date
No Press Release

Headlines

See More
  • 1
No news.
  • 1